As CD103+ DCs have been associated with the priming of robust anti-tumour CD8+ T cell responses, we analysed the dLN-resident T cell compartment with respect to the presence of CD8+ vs. CD4+ T cells. The gene discussed is CD4; the disease is neoplasm.